ERENUMAB

Molecular Identity

AntibodyApprovedFirst approved 2018

Mechanism of action: Calcitonin gene-related peptide type 1 receptor antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

AimovigAMG 334AMG-334ERENUMABERENUMAB AOOEERENUMAB-AOOE

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ERENUMAB

Loading drug network...